Medical devices, healthcare technology and the business of care
510(k) clearance · K262683

VITEK PRO

bioMérieux, Inc. · Decision date Nov 3, 2026

MEDTECHLEDGER EXPLANATIONK262683

What did the FDA decide?

FDA recorded a substantial equivalence decision (SESE) for VITEK PRO, submitted by bioMérieux, Inc. under 510(k) number K262683, with a decision date of 2026-11-03. The product code is LON and the listed specialty is microbiology. The record describes the VITEK PRO as an automated diagnostic system for identification and antimicrobial susceptibility testing, and as in vitro diagnostic test software for those purposes.

The available excerpts state that the submitted information in the premarket notification is complete and supports a substantial equivalence decision, so this is a 510(k) clearance rather than a PMA approval. The excerpts also reference the Advanced Expert System for online validation of results and interpretation of resistant phenotypes, and note that quality control should follow the package insert protocol for each AST card and antimicrobial agent. The record does not identify a prior predicate device, the specific cleared test menu, or the full indications for use.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Microbiology
Decision date
Nov 3, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262683
Regulatory pathway
510(k) premarket notification
Product code
LON
Decision code
SESE
Decision date
Nov 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation.

Product code
LON
FDA device class
2

FDA decision timeline

  1. K262683 received

    Application receipt date recorded by FDA.

  2. K262683 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LON

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

bioMérieux, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hazelwood, MO

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records